GHET1 promotes prostate cancer progression through targeting KLF2 which activates the HIF-1alpha/NOTCH-1 pathway, and MACC1-AS1 drives pancreatic cancer progression through activating PAX8/NOTCH1 signaling (97,98). Here, NOTCH1 is linked to prostate carcinoma.